APLN and Stroke: Specifically, adipokines like apelin, NAMPT, and adiponectin have demonstrated remarkable neuroprotective qualities in various experimental models, suggesting their potential as therapeutic agents to reduce neuronal damage and improve outcomes in conditions such as strokes and neurodegenerative diseases.